The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: A Markov decision analysis approach

Laryngoscope

Volumn 121, Issue 5, 2011, Pages 952-960

  Dedhia, Raj C ^a   Smith, Kenneth J ^a   Johnson, Jonas T ^a   Roberts, Mark ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

General otolaryngology; head and neck

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ALCOHOL ABUSE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; GLOSSECTOMY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MOUTH CANCER; NECK DISSECTION; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SMOKING; UNITED STATES;

ADULT; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; MOUTH NEOPLASMS; RISK FACTORS; UNITED STATES;

EID: 79955541895     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21412     Document Type: Article

References (39)

1. Jameson MJLP., Neoplasms of the Oral Cavity. In:, Johnson BJBJT, ed. Head & Neck Surgery-Otolaryngology. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 1551-1556.
2. Ling H, Gadalla S, Israel E, et al. Oral cancer exams among cigarette smokers in Maryland. Cancer Detect Prev 2006; 30: 499-506. (Pubitemid 44828296)
3. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 2004; 101: 3-27. (Pubitemid 38812419)
4. Scattoloni J,. Screening for Oral Cancer: Brief Evidence Update.
5. Sankaranarayanan R, Ramadas K, Thomas G, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005; 365: 1927-1933. (Pubitemid 40797502)
6. Cruz GD, Le Geros RZ, Ostroff JS, Hay JL, Kenigsberg H, Franklin DM., Oral cancer knowledge, risk factors and characteristics of subjects in a large oral cancer screening program. J Am Dent Assoc 2002; 133: 1064-1071; quiz 1094.
7. Gourin CG, Kaboli KC, Blume EJ, Nance MA, Koch WM., Characteristics of participants in a free oral, head and neck cancer screening program. Laryngoscope 2009; 119: 679-682.
8. Jullien JA, Zakrzewska JM, Downer MC, Speight PM., Attendance and compliance at an oral cancer screening programme in a general medical practice. Eur J Cancer B Oral Oncol 1995; 31B: 202-206.
9. Poh CF, Hislop G, Currie B, et al. Oral cancer screening in a high-risk underserved community-Vancouver Downtown Eastside. J Health Care Poor Underserved 2007; 18: 767-778.
10. Kolker JL, Ismail AI, Sohn W, Ramaswami N., Trends in the incidence, mortality, and survival rates of oral and pharyngeal cancer in a high-risk area in Michigan, USA. Community Dent Oral Epidemiol 2007; 35: 489-499.
11. Beck JR, Pauker SG., The Markov process in medical prognosis. Med Decis Making 1983; 3: 419-458. (Pubitemid 14196965)
12. Shah JP, Johnson NW, Batsakis JG., Oral Cancer. London: Martin Dunitz; Distributed in the US by Thieme New York; 2003: 496 p.
13. Arias E., United States life tables, 2004. Natl Vital Stat Rep 2007; 56: 1-39.
14. Gold MR., Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996: xxiii.
15. Nagao T, Ikeda N, Fukano H, Hashimoto S, Shimozato K, Warnakulasuriya S., Incidence rates for oral leukoplakia and lichen planus in a Japanese population. J Oral Pathol Med 2005; 34: 532-539. (Pubitemid 41337059)
16. Maserejian NN, Joshipura KJ, Rosner BA, Giovannucci E, Zavras AI., Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev 2006; 15: 774-781.
17. Silverman S Jr, Gorsky M, Lozada F., Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53: 563-568. (Pubitemid 14182737)
18. Werning JW., Oral Cancer: Diagnosis, Management, and Rehabilitation. New York: Thieme Medical Publishers; 2007: xiii.
19. Napier SS, Speight PM., Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37: 1-10. (Pubitemid 350264786)
20. van der Waal I, Schepman KP, van der Meij EH, Smeele LE., Oral leukoplakia: a clinicopathological review. Oral Oncol 1997; 33: 291-301. (Pubitemid 28129229)
21. Ferlito A, Silver CE, Rinaldo A., Elective management of the neck in oral cavity squamous carcinoma: current concepts supported by prospective studies. Br J Oral Maxillofac Surg 2009; 47: 5-9.
22. Liu SY, Lu CL, Chiou CT, et al. Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan. Oral Oncol 2010: 46: 276-282.
23. Shingaki S, Kobayashi T, Suzuki I, Kohno M, Nakajima T., Surgical treatment of stage I and II oral squamous cell carcinomas: analysis of causes of failure. Br J Oral Maxillofac Surg 1995; 33: 304-308.
24. Hinerman RW, Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Villaret DB., Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck 2004; 26: 984-994. (Pubitemid 39488127)
25. Sun GW, Tang EY, Yang XD, Hu QG., Salvage treatment for recurrent oral squamous cell carcinoma. J Craniofac Surg 2009; 20: 1093-1096.
26. Sox HC., Medical Decision Making. Boston, MA: Butterworths; 1988: 406 p.
27. Jullien JA, Downer MC, Zakrzewska JM, Speight PM., Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health 1995; 12: 3-7.
28. Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK., Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer 1997; 76: 390-394. (Pubitemid 27308092)
29. HCUP Overview. Healthcare Cost and Utilization Project (HCUP). November 2009. Agency for Healthcare Research and Quality, Rockville, MD. Available at:v.
30. Vokes EE, Schilsky RL, Choi KE, et al. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer 1989; 63: 30-36. (Pubitemid 19031977)
31. Mundt AJ, Roeske JC., Intensity Modulated Radiation Therapy: A Clinical Perspective. Lewiston, NY: BC Decker; 2005: xxiv.
32. Gold MR, Franks P, McCoy KI, Fryback DG., Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998; 36: 778-792. (Pubitemid 128454315)
33. Downer MC, Jullien JA, Speight PM., An interim determination of health gain from oral cancer and precancer screening: 1. Obtaining health state utilities. Community Dent Health 1997; 14: 139-142. (Pubitemid 127520562)
34. American Cancer Society. Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society; 2009.
35. Pindborg JJ, Roed-Peterson B, Renstrup G., Role of smoking in floor of the mouth leukoplakias. J Oral Pathol 1972; 1: 22-29.
36. Menzin J, Lines LM, Manning LN., The economics of squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 68-73. (Pubitemid 46594856)
37. Lang K, Sussman M, Friedman M, et al. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2009; 135: 582-588.
38. Schepman KP, van der Meij EH, Smeele LE, van der Waal I., Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998; 34: 270-275. (Pubitemid 28318253)
39. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS., What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008; 46: 349-356.